Thomson Pharma Enhances its Information

Apr 14, 2006

Thomson Scientific, a business of The Thomson Corporation, announced that Thomson Pharma will display comprehensive Supplementary Protection Certificate (SPC) expiration dates. Considered the European equivalent of Hatch Waxman--the US law that allows patent extensions to compensate for time lost while a patented drug gains regulatory approval--SPCs act as a supplement to the patent's protection by coming into force at the expiration date of the drug's patent. Thus, SPCs give the drug owner exclusive rights to market the drug for an additional period.